N/A N=114 Randomized Single-blind Treatment

Comparison of Couple-Based PTSD Treatment and Couple-Based PTSD Education

Stress Disorders, Post-Traumatic

Bottom Line

View on ClinicalTrials.gov: NCT01022203 ↗

Enrolled (actual)

114

Serious AEs

0.0%

Results posted

Mar 2015

Primary outcome: Primary: Psychological Functioning — 82.93; 82.93; 60.84; 60.81 units on a scale — p=<0.0001

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Structured Approach Therapy (Behavioral); PTSD Family Education (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: VA Office of Research and Development
Primary completion: Dec 2013

Outcome Measures

Outcome	Result	p-value
PRIMARY Psychological Functioning	82.93; 82.93; 60.84; 60.81; 48.33; 72.59	<0.0001 sig
SECONDARY Relationship Functioning	93.34; 101.82; 105.18; 101.77; 106.76; 101.95	<0.001 sig
SECONDARY Emotion Regulation	106.6; 106.4; 88.7; 106.4; 87.29; 105.75	<0.0001 sig

Summary

The study is designed to evaluate the efficacy of a novel couple-based treatment for PTSD, called Structured Approach Therapy, to decrease PTSD and improve the marital and social functioning of Iraqi war Veterans and their partners. The effectiveness of couples therapy will be compared with the effectiveness of a couple-based educational intervention.

Eligibility Criteria

Inclusion Criteria

Exposure to at least one combat-related stressful event during combat deployment,
Current diagnostic criteria for PTSD for that event, and
Veteran is in a committed relationship and living with an opposite sex partner for at least six months.

Exclusion Criteria

Current psychotic symptoms in either partner,
Current diagnosis of alcohol or drug dependence in either partner,
History of recent physical assault/abuse,
Currently receiving an evidence-based PTSD treatment (exposure-based or cognitive processing therapy)
Currently receiving couples therapy or family therapy

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01022203). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.